Results of research at the University of Kansas Medical Center investigating the benefit of Oxeia Biopharmaceuticals’ drug therapy for treating subacute concussion published in the April issue of the American Congress of Rehabilitation Medicine’s journal, Archives of Physical Medicine and Rehabilitation online.

https://www.archives-pmr.org/article/S0003-9993(24)00402-7/abstract